Actinium Pharmaceuticals, Inc. (ATNM)
R&D to Revenue
23471.11%
Fiscal year · Period ending:
ATNM R&D to Revenue
Latest reported23471.11%period ending
Latest reported23471.11%period ending
ATNM FY R&D/Revenue (0.00% → 23471.11%)
Latest values, visible window
High-resolution chart · PNG
ATNM r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 23,471.1111% | |
| 0% | |
| 47,740.7407% | |
| 2,246.1165% | |
| 1,530.3322% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |